• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Dementia Management Update"

    (session captured at the GAPNA 2018 Annual Conference)

    For September/October 2019 - Get Your Free CNE Now!

Medicare Part D Coverage Gap Reduces Antidepressant Use in the Elderly

The Medicare Part D prescription drug benefit includes a $265 deductible, an insured period during which the beneficiary pays 25%of drug costs from $265 to $2,400, and a coverage gap when the beneficiary pays 100 percent of drug costs until reaching the catastrophic limit of $3,850; then they pay 5%.

A new study found elderly Medicare patients with depression enrolled in stand-alone Part D plans in 2007 reduced their use of antidepressants during the Medicare Part D coverage gap.

In fact, a full gap in drug coverage resulted in a 12.1% reduction in antidepressant use, particularly for brand-name drugs.

For more info, see Zhang, Y. et al. (2012). Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. Archives of General Psychiatry, 69(7), 672-679.

Related Topic 1: 

GAPNA Newsletter Issue: